Markel Corporation (MKL) - FREE Research Report

Kirshner Alan I who is Chairman and CEO at Markel Corporation sold 2,000 shares at $539.32 on Nov. 22, 2013. Following this transaction, the Chairman and CEO owned 27,762 shares meaning that the stake was reduced by 6.72% with the 2,000 share transaction.

The shares most recently traded at $557.22, up $17.90, or 3.21% since the insider transaction. Historical insider transactions for Markel Corporation go as follows:

  • 4-Week # shares sold: 96
  • 12-Week # shares sold: 96
  • 24-Week # shares bought: 150
  • 24-Week # shares sold: 396

The average volume for Markel Corporation has been 45,900 shares per day over the past 30 days. Markel Corporation has a market cap of $7.6 billion and is part of the financial sector and insurance industry. Shares are up 27.21% year to date as of the close of trading on Friday.

Markel Corporation markets and underwrites specialty insurance products in the United States and internationally. It operates in three segments: Excess and Surplus Lines, Specialty Admitted, and London Insurance Market. The company has a P/E ratio of 25.3. Currently there is 1 analyst that rates Markel Corporation a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MKL - FREE

TheStreet Quant Ratings rates Markel Corporation as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, increase in stock price during the past year, increase in net income and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Markel Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Automation Threatens Some Staffing Agencies According to Credit Suisse

20 Mid-Cap Dividend Growers Are Blips on My Tracking Radar

The Art of Setting Price Targets

Taking Points - or Profits - Off the Board